Rennova Health Inc (RNVA)

[nfrequent]

.0025/.025/.25 ballpark targets. Short-term based on current EPS at a P/E of 25. Medium and long-term based on current trajectory of earnings growth at a P/E of 25. Could reach .025 this year on more good news and some healthy speculation. In other words, I would take .0025 if a run bargain this week, but will be more inclined to hold the closer we get to the Q3 earnings report.

I refuse to get caught out of position in RNVA. Too much certainty in the earnings growth to do that.